EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neuroimmune Mechanisms in Alcohol Use Disorder: Microglial Modulation and Therapeutic Horizons

Jiang-Hong Ye, Wanhong Zuo, Faraz Chaudhry, Lawrence Chinn

Psychoactives · 04.09.2025 · 4 (3) · 33

DOI: 10.3390/psychoactives4030033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychoactives, online erschienen am 04.09.2025. Verfasst von Jiang-Hong Ye und 3 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alcohol Use Disorder (AUD) profoundly impacts individuals and society, driven by neurobiological adaptations that sustain chronicity and relapse. Emerging research highlights neuroinflammation, particularly microglial activation, as a central mechanism in AUD pathology. Ethanol engages microglia—the brain’s immune cells—through key signaling pathways such as Toll-like receptor 4 (TLR4) and the NLRP3 inflammasome, triggering the release of proinflammatory cytokines (IL-1β, TNF-α, IL-6). These mediators alter synaptic plasticity in addiction-related brain regions, including the ventral tegmental area, nucleus accumbens, amygdala, and lateral habenula, thereby exacerbating cravings, withdrawal symptoms, and relapse risk. Rodent models reveal that microglial priming disrupts dopamine signaling, heightening impulsivity and anxiety-like behaviors. Human studies corroborate these findings, demonstrating increased microglial activation markers in postmortem AUD brains and neuroimaging analyses. Notably, sex differences influence microglial reactivity, complicating AUD’s neuroimmune landscape and necessitating sex-specific research approaches. Microglia-targeted therapies—including minocycline, ibudilast, GLP-1 receptor agonists, and P2X7 receptor antagonists—promise to mitigate neuroinflammation and reduce alcohol intake, yet clinical validation remains limited. Addressing gaps such as biomarker identification, longitudinal human studies, and developmental mechanisms is critical. Leveraging multi-omics tools and advanced neuroimaging can refine microglia-based therapeutic strategies, offering innovative avenues to break the self-sustaining cycle of AUD.

Zitieren

APA

Ye, J., Zuo, W., Chaudhry, F., & Chinn, L. (2025). Neuroimmune Mechanisms in Alcohol Use Disorder: Microglial Modulation and Therapeutic Horizons. Psychoactives, 4(3), 33. https://doi.org/10.3390/psychoactives4030033

Vancouver

Ye J, Zuo W, Chaudhry F, Chinn L. Neuroimmune Mechanisms in Alcohol Use Disorder: Microglial Modulation and Therapeutic Horizons. Psychoactives. 2025;4(3):33. doi:10.3390/psychoactives4030033

BibTeX
@article{Ye2025,
  author = {Ye, Jiang-Hong and Zuo, Wanhong and Chaudhry, Faraz and Chinn, Lawrence},
  title = {Neuroimmune Mechanisms in Alcohol Use Disorder: Microglial Modulation and Therapeutic Horizons},
  journal = {Psychoactives},
  year = {2025},
  volume = {4},
  number = {3},
  pages = {33},
  doi = {10.3390/psychoactives4030033}
}
Kostenlos starten →